rBet v 1
Showing 1 - 25 of >10,000
Lentigo Solar Trial in Batumi (Prototypes (815-v1 001) to (815-v1 050), Prototype (815-v1 051) to (815-v1 100), Prototypes
Not yet recruiting
- Lentigo Solar
- Prototypes (815-v1 001) to (815-v1 050)
- +3 more
-
Batumi, GeorgiaLtd "Health"
Nov 18, 2022
Lentigo Solar, Senile Lentigo Trial in Batumi (Prototypes (816-v1 301) to (816-v1 355) every week, Prototypes (816-v1 301) to
Not yet recruiting
- Lentigo Solar
- Senile Lentigo
- Prototypes (816-v1 301) to (816-v1 355) every week
- Prototypes (816-v1 301) to (816-v1 355) every two weeks
-
Batumi, GeorgiaLtd "Health"
Mar 31, 2023
HIV-1-infection Trial in Amsterdam (ConM SOSIP.v7 gp140, adjuvanted with MPLA liposomes)
Active, not recruiting
- HIV-1-infection
- ConM SOSIP.v7 gp140, adjuvanted with MPLA liposomes
-
Amsterdam, Noord-Holland, NetherlandsAmsterdam University Medical Centers, location AMC
Jan 31, 2023
PreDiabetes, Prediabetic State Trial in Kelowna (Small Steps for Big Changes Program)
Not yet recruiting
- PreDiabetes
- Prediabetic State
- Small Steps for Big Changes Program
-
Kelowna, British Columbia, CanadaUniversity of British Columbia
Jul 24, 2023
Solar Lentigo, Senile Lentigo, Post-inflammatory Hyperpigmentation Trial in Pretoria (Prototypes (816-v1 001) to (816-v1 050),
Not yet recruiting
- Solar Lentigo
- +2 more
- Prototypes (816-v1 001) to (816-v1 050)
- +3 more
-
Pretoria, South AfricaSMU - Photobiology Laboratory, Sefako Makgatho Health Sciences U
Nov 18, 2022
Mild Cognitive Impairment Trial in Tallahassee, Champaign, New York (Project 1, Phase 2: VR Program for Social, Activity, and
Not yet recruiting
- Mild Cognitive Impairment
- Project 1, Phase 2: VR Program for Social, Activity, and Cognitive Engagement
- +2 more
-
Tallahassee, Florida
- +2 more
Mar 30, 2023
Measurement Information System-29 v2.1 for Postpartum Women
Not yet recruiting
- Well-Being, Psychological
- PROMIS-29 v2.1 (Patient-Reported Outcomes Measurement Information System)
- +2 more
-
Toronto, Ontario, CanadaMount Sinai Hospital
Aug 16, 2023
Solar Lentigo Trial in Zhytomyr (Prototypes (812A-v1), (812C-v1), (812D-v1) and (812F-v1))
Completed
- Solar Lentigo
- Prototypes (812A-v1), (812C-v1), (812D-v1) and (812F-v1)
-
Zhytomyr, UkraineVIDNOVLENNYA medical center
Aug 18, 2022
Depression, Serotonin Deficiency Trial in Kelowna (Pharmacological agent: Citalopram, Placebo)
Not yet recruiting
- Depression
- Serotonin Deficiency
- Pharmacological agent: Citalopram
- Placebo
-
Kelowna, British Columbia, CanadaUniversity of British Columbia, Okanagan Campus
Jul 19, 2023
Monitoring T Cell Responses in Melanoma, Lung and Other Cancer
Recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- +9 more
- Biospecimen Collection
- Electronic Health Record Review
-
Rochester, MinnesotaMayo Clinic in Rochester
Oct 4, 2023
Learn About Interferon-beta Exposure of Pregnant Women During
Not yet recruiting
- Multiple Sclerosis (MS)
- Avonex (IFNβ-1-a, Biogen Netherlands B.V)
- +5 more
-
Multiple Locations, Finland
- +1 more
Sep 19, 2023
Allergic Rhinitis, Conjunctivitis Trial (REGN5713, REGN5714, REGN5715)
Not yet recruiting
- Allergic Rhinitis
- Conjunctivitis
- REGN5713
- +3 more
- (no location specified)
Jun 20, 2022
Metabolic Diseases, Aging Problems Trial in Kelowna (Fed, Fasted)
Not yet recruiting
- Metabolic Diseases
- Aging Problems
- Fed
- Fasted
-
Kelowna, British Columbia, CanadaUniversity of British Columbia - Okanagan Campus
Aug 22, 2023
Hiv Trial in United States (V3G CH848 Pr-NP1 60mcg, 3M-052-AF 5mcg, Alum 500 mcg)
Not yet recruiting
- Hiv
- V3G CH848 Pr-NP1 60mcg
- +5 more
-
Birmingham, Alabama
- +5 more
Jun 5, 2023
Solid Tumor Trial in Kashiwa-shi, Matsuyama-shi, Koto-Ku (M1-c6v1)
Not yet recruiting
- Solid Tumor
- M1-c6v1
-
Kashiwa-shi, Chiba, Japan
- +2 more
Sep 19, 2023
Alzheimer's Disease, Dementia, Brain Diseases Trial in Daejeon, Busan, Seoul (ATNC MDD-V1 (Real TMS + Real Cog), ATNC MDD-V1
Recruiting
- Alzheimer's Disease
- +7 more
- ATNC MDD-V1 (Real TMS + Real Cog)
- ATNC MDD-V1 (Sham TMS + Real Cog)
-
Daejeon, Jung-gu, Korea, Republic of
- +2 more
Oct 11, 2023
Metastatic Colorectal Adenocarcinoma, Metastatic Small Intestinal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v8 Trial in
Recruiting
- Metastatic Colorectal Adenocarcinoma
- +6 more
- Biopsy
- +8 more
-
Houston, TexasM D Anderson Cancer Center
Jan 20, 2023
Healthy Trial (763SIP8/MPLA-5 vaccine)
Not yet recruiting
- Healthy
- 763SIP8/MPLA-5 vaccine
- (no location specified)
Mar 15, 2023
Developmental Dyslexia Trial in Roma (Active HD-tDCS over V5/MT, Active HD-tDCS over V1, Sham HD-tDCS over V5/MT or V1)
Recruiting
- Developmental Dyslexia
- Active HD-tDCS over V5/MT
- +2 more
-
Roma, ItalyBambino Gesù Hospital and Research Institute
Aug 2, 2023
HIV-1-infection Trial in Saint Louis (Biktarvy Tab)
Terminated
- HIV-1-infection
- Biktarvy Tab
-
Saint Louis, MissouriSouthampton Healthcare, Inc.
Jan 3, 2023
H1N1v Influenza Trial in Gentofte/Copenhagen, Næstved (Focetria)
Completed
- H1N1v Influenza
- Focetria
-
Gentofte, Denmark
- +1 more
Nov 14, 2022
Diabetes, Type 2, Hyperglycemia, Ketosis Trial in Kelowna (Dietary Supplement: D-ß-hydroxybutyric acid with R-1,3-butanediol,
Recruiting
- Diabetes Mellitus, Type 2
- +2 more
- Dietary Supplement: D-β-hydroxybutyric acid with R-1,3-butanediol
- Inert placebo
-
Kelowna, British Columbia, CanadaUniversity of British Columbia Okanagan
Aug 1, 2023
Asthma Trial in Canada (Vitamin D, Placebo)
Recruiting
- Asthma
- Vitamin D
- Placebo
-
Vancouver, British Columbia, Canada
- +8 more
Jan 30, 2023
Vitiligo Trial in Cairo (Narrow band UVB)
Active, not recruiting
- Vitiligo
- Narrow band UVB
-
Cairo, El Manial, EgyptKasr El Ainy university hospital, Faulty of medicine,Cairo unive
Mar 10, 2022
Sublingual Microcirculation in Compensated T1D Using SDF Method
Recruiting
- Type1diabetes
-
Ústí Nad Labem, CzechiaMasarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s.
Jul 14, 2023